/SFOSF
SFOSF Stock - Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Healthcare|Drug Manufacturers - Specialty & GenericOTC
$2.77-16.06%
$0.53 (-16.06%) • Dec 19
65
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.50
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.91
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $3.05
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for SFOSF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$2.74 – $2.80
TARGET (TP)$3.19
STOP LOSS$2.55
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.73
52W High$3.50
52W Low$1.62
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $41.07B | $41.40B | $43.95B | $39.01B | $30.31B |
| Gross Profit | $19.70B | $19.80B | $20.78B | $18.78B | $16.88B |
| Gross Margin | 48.0% | 47.8% | 47.3% | 48.1% | 55.7% |
| Operating Income | $4.25B | $3.31B | $8.30B | $6.31B | $4.72B |
| Net Income | $2.77B | $2.39B | $3.73B | $4.73B | $3.66B |
| Net Margin | 6.7% | 5.8% | 8.5% | 12.1% | 12.1% |
| EPS | $1.04 | $0.89 | $1.43 | $1.85 | $1.43 |
Company Overview
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. develops, manufactures, and sells pharmaceutical products in Mainland China and internationally. It operates in five segments: Pharmaceutical Manufacturing, Medical Devices and Medical Diagnosis, Healthcare Service, Pharmaceutical Distribution and Retail, Other Business segments. The company offers pharmaceutical products in the areas of tumor, immune modulation, metabolism, alimentary and central nervous system. It also provides medical devices and diagnostic products. In addition, the company offers health care and hospital management services. Further, it engages in retail and wholesale distribution of medicines. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
SFOSFBeat Rate
29%
Last 7 quarters
Avg Surprise
-16.0%
EPS vs Estimate
Beats / Misses
2/5
Last 12 quarters
Latest EPS
$0.05
Q3 2025
EPS Surprise History
Q4 23
No data
Q1 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q1 25
No data
Q2 25
No data
Q3 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 27, 2026 | — | — | — | — |
Q4 2025 | Oct 29, 2025 | — | — | — | — |
Q3 2025 | Aug 26, 2025 | — | $0.05 | — | — |
Q2 2025 | Apr 29, 2025 | — | $0.04 | — | — |
Q1 2025 | Mar 25, 2025 | — | $0.04 | — | — |
Q4 2024 | Oct 29, 2024 | — | $0.04 | — | — |
Q3 2024 | Aug 27, 2024 | — | $0.03 | — | — |
Q2 2024 | Apr 29, 2024 | — | $0.03 | — | — |
Q1 2024 | Mar 26, 2024 | — | $0.03 | — | — |
Q4 2023 | Dec 31, 2023 | — | $0.01 | — | — |
Q2 2023 | Jun 30, 2023 | — | $0.04 | — | — |
Q1 2023 | Mar 31, 2023 | — | $0.05 | — | — |
Q1 2023 | Mar 29, 2023 | $0.06 | $0.07 | +26.3% | ✓ BEAT |
Q4 2022 | Oct 30, 2022 | — | $0.05 | — | — |
Q3 2022 | Sep 1, 2022 | $0.10 | $0.06 | -39.1% | ✗ MISS |
Q2 2022 | Apr 26, 2022 | $0.06 | $0.03 | -51.3% | ✗ MISS |
Q1 2022 | Mar 22, 2022 | $0.05 | $0.07 | +35.3% | ✓ BEAT |
Q4 2021 | Oct 26, 2021 | $0.07 | $0.07 | -10.6% | ✗ MISS |
Q3 2021 | Aug 23, 2021 | $0.15 | $0.10 | -32.6% | ✗ MISS |
Q2 2021 | Apr 24, 2021 | $0.08 | $0.05 | -40.0% | ✗ MISS |
Latest News
Loading news...
Frequently Asked Questions about SFOSF
What is SFOSF's current stock price?
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SFOSF) is currently trading at $2.77 per share. The stock has moved -16.06% today.
What is the analyst price target for SFOSF?
No analyst price targets are currently available for this stock.
What sector is Shanghai Fosun Pharmaceutical (Group) Co., Ltd. in?
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.
What is SFOSF's market cap?
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. has a market capitalization of $7.35 billion, making it a mid-cap company.
Does SFOSF pay dividends?
No, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBDULF
Bangkok Dusit Medical Services Public Company Limited
$0.61
Mkt Cap: $9.7B
BDUUF
Bangkok Dusit Medical Services Public Company Limited
$0.59
Mkt Cap: $9.4B
BIOVF
Swedish Orphan Biovitrum AB (publ)
$35.25
Mkt Cap: $12.1B
CSPCY
CSPC Pharmaceutical Group Limited
$4.21
Mkt Cap: $12.2B
ESAIY
Eisai Co., Ltd.
$7.14
Mkt Cap: $8.2B
ESALF
Eisai Co., Ltd.
$28.55
Mkt Cap: $8.1B
GIFLF
Grifols, S.A.
$11.66
Mkt Cap: $7.9B
ORINF
Orion Oyj
$81.30
Mkt Cap: $11.4B
RCDTF
Recordati Industria Chimica e Farmaceutica S.p.A.
$65.44
Mkt Cap: $13.4B
SHPMF
Shanghai Pharmaceuticals Holding Co., Ltd
$1.53
Mkt Cap: $8.5B
Explore stocks similar to SFOSF for comparison